Inergetics Inc (fka NRTI)

[crookedneck]

The Real Story here...

Some folks don't see it the way I do and that is fine, and it is true that this is a speculative stock, however, it is being run by an excellent management team that does not participate in your usual OTC tactics of pumping with big promises that never materialize. With NRTI, you won't know something has happened until it is announced, as they don't use fluff PR's to try and pump their stock. Unlike so many other OTC companies, NRTI is the real deal and the management here operates with real integrity while working to build a viable and successful company.

Sometimes things don't always pan out as originally thought and sometimes it takes longer than expected to grow a brand, which is the case with the Martha Stewart Essentials brand, whereas, they will try to renegotiate the royalty agreement to give them some breathing room at this early stage, but it sure doesn't mean that the brand won't be successful.

There is so much going on behind the scenes that many will never realize, but their unique and unprecedented approach to enter the CBD field with a huge competitive advantage is a REAL GAME CHANGER and if one understands this, they will see that NRTI has a distinct opportunity to become cash flow positive in a very short time!

The stock market is all about finding these gems before they become hugely successful. That is how you make the BIG gains and of course it requires a certain amount of risk that goes along with investing in a company at this stage, but the more you know, the less the risk.

First of all the Marijuana industry is expected to be the fastest growing sector for the next five years - "In a new analysis on the marijuana marketplace, San Francisco-based angel investor network ArcView Group forecasts a 64 percent surge in the legal U.S. cannabis market to $2.34 billion by 2014. The five-year national market could grow to $10.2 billion amid rising demand and potentially new state markets, according to ArcView forecasts." http://www.cnbc.com/id/101314084 . So when NRTI rolls out their new CBD supplements early next year with the leading Scientific & Medical experts supporting and endorsing them, they stand to garner a lot of sales with a huge profit margin in this partnership w/Terra Tech, who will grow and extract the cannabidiol that Inergetics will use in the manufacturing of these very high quality CBD supplements that will perform as labeled. You could say they are in the right place at the right time!

Meanwhile they will continue to expand and grow their present brands that are less than a year old. Anyone familiar with this business knows it takes time to build a brand, especially in the highly competitive health supplement arena, where just getting distribution is a long and tedious battle. Once they get to a point where they have an acceptable level of distribution, they can start to consider the heavy promotional activity, such as TV & print advertising, if the funding is available.

Inergetics is a company where you have to dig deep to see all that is happening beneath the surface in terms of their operational integrity and their future plans to make this company a very successful venture that will reward early investors. Speculative? Definitely, but given the current circumstances, it has a very good shot of becoming successful much sooner with their unique competitive advantage in the fastest growing sector for the next 5 years. Cheers!

PS: I have done my extensive DD and I use real data and real facts to support what I post and below is a sampling of what I use to support my position. I hope you find it useful.

CBD is the REAL FUTURE for NRTI and given their unique ground breaking approach, they will garner a significant competitive advantage in MJ marketplace that can not be replicated by competition! When the street wakes up and takes notice of this, you will see this stock soar beyond $1.00 real fast!

They will have all the Sceintific & Medical MJ experts in their corner supporting and endorsing their CBD products!

Just read these comments from their impressive Advisory Board after their first meeting and click the news links at the bottom to see where this company is headed next year!!!!!!!!!!!!!!

"We are making clear progress in the development of superior CBD-based products that will offer a natural and workable remedy to patients seeking relief from a range of symptoms," said NRTI Chief Science Officer, Carl Germano, RD, CNS, CDN. "Certain cannabinoids are non-psychoactive, and proven to provide safe and effective relief to those suffering from pain, nausea, neurological disorders and other ailments. I could not have been more pleased with the substance of our discussion, and the plan we have devised for bringing our first CBD product to market."

Advisory Board member Dr. Joseph McSherry, M.D., a Neurologist and widely recognized academic expert on medical marijuana and its many health benefits, said, "An effort such as this is unprecedented. We have come so far since I first started advocating for the medicinal applications of Cannabis, and I am excited about working with this impressive group of colleagues to bring the therapeutic properties of CBD-based supplements to the consumers who could most benefit from them."

"Cannabinoids undoubtedly provide relief from pain and its underlying symptoms, and do so with far fewer side effects than other treatments currently available," said Dr. Mark Wallace, M.D., a member of the Advisory Board and the Chair of the Division of Pain Medicine at University of California San Diego. "CBD is a clear and essential alternative remedy for patients, and I think we are all eager to make this resource available to the public, and at a higher-quality."

Advisory Board member Dr. Michelle Sexton, a certified naturopathic doctor, said, "I look forward to working with this impressive group to take the first critical look at the proper dosage, potency, purity and methods of administration of cannabinoids. Right now there is no clear industry standard, and this team has an opportunity to change that."

"Twenty-five percent of drugs in the market today come from natural sources. Cannabis is just another one of those natural sources that can be used to help patients," said Justin Fischedick, PhD, a member of the Advisory Board and an expert in plant chemistry.

Dr. Yu Shao, Advisory Board member and also a consultant for Merck, added, "Inergetics and Terra Tech can help define the future of medicinal Cannabis, and I am pleased to be a part of this effort."

The strategic partnership between Inergetics and Terra Tech Corp was announced on February 4 and the companies' first CBD-based supplements are expected to be distributed via medicinal marijuana dispensaries. Inergetics announced the formation of the Scientific/Medical Advisory Board on March 5.


IMPORTANT LINKS:

Inergetics Enters Second Phase of a Three Phase Process to Launch its CBD-Based Supplements

Inergetics Completes Phase I Development of its Therapeutic CBD Line of Products

Inergetics Holds Inaugural Meeting of its Scientific/Medical Advisory Board

Inergetics Scientific/Medical Advisory Board Member Dr. Michelle Sexton Co-authors Important Research in the Cannabis Monograph

20 Medical Studies That Prove Cannabis Can Cure Cancer

Marijuana will be the single best investment idea of the next decade:

America's Marijuana Industry Is Growing Like Weeds—Billions of Them

Marijuana Market Poised To Grow Faster Than Smartphones